Arsenic trioxide in multiple myeloma: rationale and future directions.

Arsenic trioxide in multiple myeloma: rationale and future directions.

Item
http://www.wikidata.org/entity/Q34564530
Factors determining sensitivity and resistance of tumor cells to arsenic trioxideAlterations in glutathione levels and apoptotic regulators are associated with acquisition of arsenic trioxide resistance in multiple myelomaEssential role of the voltage-dependent anion channel (VDAC) in mitochondrial permeability transition pore opening and cytochrome c release induced by arsenic trioxide.Novel HPMA copolymer-bound constructs for combined tumor and mitochondrial targeting.Opportunities for Trisenox (arsenic trioxide) in the treatment of myelodysplastic syndromes.Arsenic trioxide: an anti cancer missile with multiple warheads.Tissue factor as an effector of angiogenesis and tumor progression in hematological malignancies.The evolving use of arsenic in pharmacotherapy of malignant disease.Roxarsone induces angiogenesis via PI3K/Akt signaling.Arsenic trioxide induces selective tumour vascular damage via oxidative stress and increases thermosensitivity of tumours.Speciation, formation, stability and analytical challenges of human arsenic metabolites.How natural are 'natural herbal remedies'? A Saudi perspective.The proteasome inhibitor bortezomib promotes mitochondrial injury and apoptosis induced by the small molecule Bcl-2 inhibitor HA14-1 in multiple myeloma cells.Topoisomerase I-DNA complexes contribute to arsenic trioxide-induced apoptosis.Multifactorial Modes of Action of Arsenic Trioxide in Cancer Cells as Analyzed by Classical and Network Pharmacology.
P2860

Arsenic trioxide in multiple myeloma: rationale and future directions.

Item
http://www.wikidata.org/entity/Q34564530
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Arsenic trioxide in multiple myeloma: rationale and future directions.
@ast
Arsenic trioxide in multiple myeloma: rationale and future directions.
@en
Arsenic trioxide in multiple myeloma: rationale and future directions.
@nl
type
label
Arsenic trioxide in multiple myeloma: rationale and future directions.
@ast
Arsenic trioxide in multiple myeloma: rationale and future directions.
@en
Arsenic trioxide in multiple myeloma: rationale and future directions.
@nl
prefLabel
Arsenic trioxide in multiple myeloma: rationale and future directions.
@ast
Arsenic trioxide in multiple myeloma: rationale and future directions.
@en
Arsenic trioxide in multiple myeloma: rationale and future directions.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
Arsenic trioxide in multiple myeloma: rationale and future directions.
@en
P2093
P304
P31
P356
10.1097/00130404-200201000-00003
P433
P478
P50
P577
P698